Menu

PROGRAM
Friday, February 10th

8:00am

Registration/Visit Exhibits

8:30am

Product Theatre I - Non-CME
Supported by: Kiniksa

9:40am

Welcome and Introduction to the Symposium
Barry Greenberg, MD

9:50am

SPECIAL FEATURED LECTURE
Cardio-Oncology - Fundamentals of Recognizing and Treating Patients Receiving Chemotherapy Who Are At Risk for Developing Heart Failure

Anya Narezkina, MD

SESSION I - Strategies for Managing Risk Factors
Pam Taub, MD (Moderator)

10:10-10:25

Treating Patients with Hypertension: What Are Current Goals and How To Best Achieve Them
Christian Mende, MD

10:25-10:40

Treating Lipid Disorders: Why and How
Michael Wilkinson, MD

10:40-10:55

Treatment of Diabetes: Focus on Preventing Cardiovascular Disease
Jia Shen, MD

10:55-11:10

Exercise Training and Rehabilitation: Rationale and Best Approaches
Pam Taub, MD

11:10-11:25

Sleep Disordered Breathing: What’s New in Detecting and Treating Sleep Disordered Breathing
Atul Malhotra, MD

11:25-11:45

Q/A and Panel Discussion
Pam Taub, MD (Moderator)
Drs. Mende, Wilkinson, Shen and Malhotra (Panelists)

11:45-12:00

Visit Exhibits

12:00-1:00pm

Product Theatre II - Non-CME
The Spectrum of Heart Failure
Vladimir Yurukov PharmD, BCPS, APh, Medical Science Liaison
   • Review the Burden of HF
   • Discuss the pathophysiology
   • Discuss the diagnosis of HF
Supported by: AstraZeneca

1:00-1:20

Visit Exhibits

SESSION II - HFpEF, Amyloid and Hypertrophic Cardiomyopathy
Marcus Anthony (Tony) Urey, MD (Moderator)

1:20-1:35

Treating HFpEF in 2023: What Do the Results of Recent Clinical Trials Tell Us?
Barry Greenberg, MD

1:35-1:50

New Options for Managing Patients with Hypertrophic Cardiomyopathy
Jorge Silva Enciso, MD

1:50-2:05

Advances in the Management of Amyloid Heart Disease
Marcus Anthony (Tony) Urey, MD

2:05-2:25

Case Presentation
Andrew Willeford Pharm D, PhD (Presenter)
Drs. Greenberg, Urey and Silva Enciso (Discussants)

2:25-2:45

Coffee Break/Visit Exhibits

SESSION III – Biomarkers, Pulmonary Arterial Hypertension, Finerenone and DOACs
Barry Greenberg, MD (Moderator)

2:45-3:00

Treating Pulmonary Artery Hypertension
Demosthenes Papamatheakis, MD

3:00-3:15

Use of Direct Oral Anticoagulants (DOACs) to Prevent Thromboembolic Complications in Patients with Heart Failure
Dan Blanchard, MD

3:15-3:30

Effects of the Novel MRA Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease
Nick Wettersten, MD

3:30-3:45

How Can We Use Biomarkers Most Effectively in Managing Patients with Heart Failure?
Lori Daniels, MD

3:45-4:00

Case Discussion
Lori Daniels, MD (Presenter)
Drs. Greenberg, Papamatheakis, Wettersten and Blanchard (Discussants)

4:00

Adjourn Day 1


Saturday, February 11th

8:00am

Registration/Visit Exhibits

8:30am

Product Theatre III - CME Available
New Insights on Pulmonary Arterial Hypertension and Pulmonary Hypertension Related to Left Heart Disease
   • Differentiate the clinical presentation, hemodynamics, and diagnostic criteria for pre-capillary pulmonary arterial hypertension and post-capillary pulmonary venous hypertension related to left heart disease
   • Summarize treatment guidelines for pulmonary arterial hypertension
   • Plan a collaborative care management approach for patients with pulmonary arterial hypertension
Supported by: AKH

9:45am

Welcome and Introduction to the Day 2 of the Symposium
Barry Greenberg, MD

SESSION IV - Redefining Heart Failure Classes and Stages/Advances in Therapy
Barry Greenberg, MD (Moderator)

9:55-10:10

Redefining Heart Failure – What Do the New Guidelines Tell Us and How to Apply to Patient Management
Barry Greenberg, MD

10:10-10:25

Sacubitril/valsartan for Treating Heart Failure – What’s the Evidence and Which Patients Will Benefit?
Gregg Fonarow, MD

10:25-10:40

SGLT2 Inhibitors – Not Just for Patients with Diabetes
Jane Wilcox, MD

10:40-10:55

New and Emerging Treatments for Heart Failure
Uri Elkayam, MD

10:55-11:10

Strategies for Starting Therapies for Patients with Heart Failure – How To Successfully Balance a Polypharmaceutical Approach
Jane Wilcox, MD

11:10-11:25

Case Presentation
Ben Cruz, MD (Moderator)
Drs. Fonarow, Wilcox, Elkayam, Julia McCain, PA and Trina Huynh Pharm D (Panelists)

11:25-11:45

Visit Exhibits

11:45am-12:45pm

Product Theatre IV - Non-CME
Treatment Considerations for Patients with HFrEF and Select Updates From the 2022 HF Guideline
Scott Baron, MD
  Director of Cardiac Emergency Services at Mercy San Juan Medical Center, Carmichael, CA
  Clinical Professor of Medicine at California Northern State Medical School in Elk Grove, CA
Learning Objectives:

  • Highlight the impact of HFrEF in the United States.
  • Review a treatment option for reducing the risk of HFH and CV death in patients with HFrEF.
  • Provide an overview of selected updates to the 2022 AHA/ACC/HFSA Guideline for the management of HF.

Supported by: Merck

12:45-1:05

Visit Exhibits

SESSION V - Special Populations and Advanced Heart Failure Treatments
Eric Adler, MD (Moderator)

1:05-1:20

Rare Causes of Heart Failure Are Uncommon… Or Are They?
Eric Adler, MD

1:20-1:35

Adult Congenital Heart Disease (ACHD) – An Increasingly Common Cause of Heart Failure
Laith Alshawabkeh, MD

1:35-1:50 

When Should Patients Be Referred To A Heart Failure Specialist?
Eric Adler, MD

1:50-2:05

Treating Patients with Advanced Heart Failure: Outcomes with Advanced Therapies
Kim Hong, MD

2:05-2:25

Case Presentation
Dr. Hilary Shapiro (Presenter)
Drs. Narezkina, Alshawabkeh, Adler and Urey (Discussants)

2:25-2:45

Coffee Break/Visit Exhibits

SESSION VI - Devices to Prevent, Protect and Treat Patients with Heart Failure
Hao (Howie) Tran, MD (Moderator)

2:45-3:00

Devices to Detect Heart Failure
Hao (Howie) Tran, MD

3:00-3:15

Devices to Protect Against Thromboembolic Events
Jonathan Hsu, MD

3:15-3:30

Devices and Wearables to Protect Against Sudden Cardiac Death
David Krummen, MD

3:30-3:45

Mechanical Circulatory Support – Percutaneous Devices and How They Can Help Stabilize Patients with CAD and with HF
Ryan Reeves, MD

3:45-4:00

Devices to Improve Cardiac Function
Howie Tran, MD

4:00-4:20

Case Discussion
Howie Tran, MD (Presenter)
Drs. Hsu, Reeves and Krummen (Panelists)

4:20

Adjourn Until February 2024